Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2007;116:1234-1241
Published online before print August 20, 2007, doi: 10.1161/CIRCULATIONAHA.107.710509
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
116/11/1234    most recent
CIRCULATIONAHA.107.710509v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pou, K. M.
Right arrow Articles by Fox, C. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pou, K. M.
Right arrow Articles by Fox, C. S.
Related Collections
Right arrow Obesity
Right arrow Risk Factors
Right arrow Growth factors/cytokines
Right arrow Computerized tomography and Magnetic Resonance Imaging
Right arrow Epidemiology

(Circulation. 2007;116:1234-1241.)
© 2007 American Heart Association, Inc.


Epidemiology

Visceral and Subcutaneous Adipose Tissue Volumes Are Cross-Sectionally Related to Markers of Inflammation and Oxidative Stress

The Framingham Heart Study

Karla M. Pou, MD; Joseph M. Massaro, PhD; Udo Hoffmann, MD, MPH; Ramachandran S. Vasan, MD; Pal Maurovich-Horvat, MD; Martin G. Larson, ScD; John F. Keaney, Jr, MD, PhD; James B. Meigs, MD, MPH; Izabella Lipinska, PhD; Sekar Kathiresan, MD; Joanne M. Murabito, MD, ScM; Christopher J. O’Donnell, MD, MPH; Emelia J. Benjamin, MD, ScM*; Caroline S. Fox, MD, MPH*

From the National Heart, Lung, and Blood Institute’s Framingham Heart Study, Framingham, Mass (J.M. Massaro, R.S.V., M.G.L., J.M. Murabito, C.J.D., E.J.B., C.S.F.); Division of Endocrinology, Metabolism, and Diabetes, Brigham and Women’s Hospital and Harvard Medical School, Boston, Mass (K.M.P., C.S.F.); Boston University School of Public Health, Departments of Biostatistics (J.M. Massaro, M.G.L.) and Epidemiology (E.J.B.), Boston, Mass; Cardiac MR PET CT Program, Massachusetts General Hospital, Harvard Medical School, Boston, Mass (U.H.); Department of Cardiology (R.S.V., J.F.K., E.J.B.) and Preventive Medicine (R.S.V., E.J.B.), Whitaker Cardiovascular Institute (R.S.V., J.F.K., I.L., E.J.B.), Boston University School of Medicine, Boston, Mass; Semmelweis University, Budapest, Hungary (P.M.-H.); General Medicine Division, Massachusetts General Hospital, Harvard Medical School, Boston, Mass (J.B.M.); the Division of Cardiology, Massachusetts General Hospital and Harvard Medical School, Boston, Mass (C.J.D., S.K.); and Section of General Internal Medicine, Boston University School of Medicine, Boston, Mass (J.M. Murabito).

Correspondence to Caroline S. Fox, MD, MPH, 73 Mt Wayte Ave, Suite 2, Framingham, MA 01702. E-mail foxca{at}nhlbi.nih.gov

Received April 19, 2007; accepted July 18, 2007.

Background— Excess adiposity is associated with greater systemic inflammation. Whether visceral adiposity is more proinflammatory than subcutaneous abdominal adiposity is unclear.

Methods and Results— We examined the relations of abdominal subcutaneous adipose tissue (SAT) and visceral adipose tissue (VAT), assessed by multidetector computerized tomography, to circulating inflammatory and oxidative stress biomarkers in 1250 Framingham Heart Study participants (52% women; age 60±9 years). Biomarkers were examined in relation to increments of SAT and VAT after adjustment for age, sex, smoking, physical activity, menopause, hormone replacement therapy, alcohol, and aspirin use; additional models included body mass index and waist circumference. SAT and VAT were positively and similarly (with respect to strength of association) related to C-reactive protein, fibrinogen, intercellular adhesion molecule-1, interleukin-6, P-selectin, and tumor necrosis factor receptor-2 (multivariable model R2 0.06 to 0.28 [SAT] and 0.07 to 0.29 [VAT]). However, compared with SAT, VAT was more highly associated with urinary isoprostanes and monocyte chemoattractant protein-1 (SAT versus VAT comparison: isoprostanes, R2 0.07 versus 0.10, P=0.002; monocyte chemoattractant protein-1, R2 0.07 versus 0.08, P=0.04). When body mass index and waist circumference were added to the models, VAT remained significantly associated with only C-reactive protein (P=0.0003 for women; P=0.006 for men), interleukin-6 (P=0.01), isoprostanes (P=0.0002), and monocyte chemoattractant protein-1 (P=0.008); SAT only remained associated with fibrinogen (P=0.01).

Conclusions— The present cross-sectional data support an association between both SAT and VAT with inflammation and oxidative stress. The data suggest that the contribution of visceral fat to inflammation may not be completely accounted for by clinical measures of obesity (body mass index and waist circumference).


 

CLINICAL PERSPECTIVE




This article has been cited by other articles:


Home page
HypertensionHome page
V. Pialoux, A. D. Brown, R. Leigh, C. M. Friedenreich, and M. J. Poulin
Effect of Cardiorespiratory Fitness on Vascular Regulation and Oxidative Stress in Postmenopausal Women
Hypertension, November 1, 2009; 54(5): 1014 - 1020.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
S. Baglioni, M. Francalanci, R. Squecco, A. Lombardi, G. Cantini, R. Angeli, S. Gelmini, D. Guasti, S. Benvenuti, F. Annunziato, et al.
Characterization of human adult stem-cell populations isolated from visceral and subcutaneous adipose tissue
FASEB J, October 1, 2009; 23(10): 3494 - 3505.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
S. Sam, S. Haffner, M. H. Davidson, R. B. D'Agostino Sr., S. Feinstein, G. Kondos, A. Perez, and T. Mazzone
Hypertriglyceridemic Waist Phenotype Predicts Increased Visceral Fat in Subjects With Type 2 Diabetes
Diabetes Care, October 1, 2009; 32(10): 1916 - 1920.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
O. Bouillanne, C. Dupont-Belmont, P. Hay, B. Hamon-Vilcot, L. Cynober, and C. Aussel
Fat mass protects hospitalized elderly persons against morbidity and mortality
Am. J. Clinical Nutrition, September 1, 2009; 90(3): 505 - 510.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
V. Gilsanz, J. Chalfant, A. O. Mo, D. C. Lee, F. J. Dorey, and S. D. Mittelman
Reciprocal Relations of Subcutaneous and Visceral Fat to Bone Structure and Strength
J. Clin. Endocrinol. Metab., September 1, 2009; 94(9): 3387 - 3393.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Khera, G. L. Vega, S. R. Das, C. Ayers, D. K. McGuire, S. M. Grundy, and J. A. de Lemos
Sex Differences in the Relationship between C-Reactive Protein and Body Fat
J. Clin. Endocrinol. Metab., September 1, 2009; 94(9): 3251 - 3258.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
E. Lapice, S. Maione, L. Patti, P. Cipriano, A. A. Rivellese, G. Riccardi, and O. Vaccaro
Abdominal Adiposity Is Associated With Elevated C-Reactive Protein Independent of BMI in Healthy Nonobese People
Diabetes Care, September 1, 2009; 32(9): 1734 - 1736.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
A. Cartier, M. Cote, I. Lemieux, L. Perusse, A. Tremblay, C. Bouchard, and J.-P. Despres
Sex differences in inflammatory markers: what is the contribution of visceral adiposity?
Am. J. Clinical Nutrition, May 1, 2009; 89(5): 1307 - 1314.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
M. F. MacKay, S. M. Haffner, L. E. Wagenknecht, R. B. D'Agostino Jr., and A. J.G. Hanley
Prediction of Type 2 Diabetes Using Alternate Anthropometric Measures in a Multi-Ethnic Cohort: The Insulin Resistance Atherosclerosis Study
Diabetes Care, May 1, 2009; 32(5): 956 - 958.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
S. H. Jain, J. M. Massaro, U. Hoffmann, G. A. Rosito, R. S. Vasan, A. Raji, C. J. O'Donnell, J. B. Meigs, and C. S. Fox
Cross-Sectional Associations Bet ween Abdominal and Thoracic Adipose Tissue Compartments and Adiponectin and Resistin in the Framingham Heart Study
Diabetes Care, May 1, 2009; 32(5): 903 - 908.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
S. Sam, S. Haffner, M. H. Davidson, R. B. D'Agostino Sr., S. Feinstein, G. Kondos, A. Perez, and T. Mazzone
Relation of Abdominal Fat Depots to Systemic Markers of Inflammation in Type 2 Diabetes
Diabetes Care, May 1, 2009; 32(5): 932 - 937.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
A. A. Mahabadi, J. M. Massaro, G. A. Rosito, D. Levy, J. M. Murabito, P. A. Wolf, C. J. O'Donnell, C. S. Fox, and U. Hoffmann
Association of pericardial fat, intrathoracic fat, and visceral abdominal fat with cardiovascular disease burden: the Framingham Heart Study
Eur. Heart J., April 1, 2009; 30(7): 850 - 856.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
J. S. Rana, B. J. Arsenault, J.-P. Despres, M. Cote, P. J. Talmud, E. Ninio, J. W. Jukema, N. J. Wareham, J. J.P. Kastelein, K.-T. Khaw, et al.
Inflammatory biomarkers, physical activity, waist circumference, and risk of future coronary heart disease in healthy men and women
Eur. Heart J., February 18, 2009; (2009) ehp010v1.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
D. T. Smith, L. J. Carr, C. Dorozynski, and C. Gomashe
Internet-delivered lifestyle physical activity intervention: limited inflammation and antioxidant capacity efficacy in overweight adults
J Appl Physiol, January 1, 2009; 106(1): 49 - 56.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
M. Hamer and A. Steptoe
Prospective study of physical fitness, adiposity, and inflammatory markers in healthy middle-aged men and women
Am. J. Clinical Nutrition, January 1, 2009; 89(1): 85 - 89.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
G. R. Hajer, T. W. van Haeften, and F. L.J. Visseren
Adipose tissue dysfunction in obesity, diabetes, and vascular diseases
Eur. Heart J., December 2, 2008; 29(24): 2959 - 2971.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
J. A. Young, S.-J. Hwang, M. J. Sarnak, U. Hoffmann, J. M. Massaro, D. Levy, E. J. Benjamin, M. G. Larson, R. S. Vasan, C. J. O'Donnell, et al.
Association of Visceral and Subcutaneous Adiposity with Kidney Function
Clin. J. Am. Soc. Nephrol., November 1, 2008; 3(6): 1786 - 1791.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. M. Apovian, S. Bigornia, M. Mott, M. R. Meyers, J. Ulloor, M. Gagua, M. McDonnell, D. Hess, L. Joseph, and N. Gokce
Adipose Macrophage Infiltration Is Associated With Insulin Resistance and Vascular Endothelial Dysfunction in Obese Subjects
Arterioscler Thromb Vasc Biol, September 1, 2008; 28(9): 1654 - 1659.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
E. Yamamoto, Y.-F. Dong, K. Kataoka, T. Yamashita, Y. Tokutomi, S. Matsuba, H. Ichijo, H. Ogawa, and S. Kim-Mitsuyama
Olmesartan Prevents Cardiovascular Injury and Hepatic Steatosis in Obesity and Diabetes, Accompanied by Apoptosis Signal Regulating Kinase-1 Inhibition
Hypertension, September 1, 2008; 52(3): 573 - 580.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
N. Stefan, K. Kantartzis, J. Machann, F. Schick, C. Thamer, K. Rittig, B. Balletshofer, F. Machicao, A. Fritsche, and H.-U. Haring
Identification and Characterization of Metabolically Benign Obesity in Humans
Arch Intern Med, August 11, 2008; 168(15): 1609 - 1616.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. Sanz, P. R. Moreno, and V. Fuster
The year in atherothrombosis.
J. Am. Coll. Cardiol., March 4, 2008; 51(9): 944 - 955.
[Full Text] [PDF]